Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Guisot, NES"'
Autor:
Purvis, GSD, Collino, M, Aranda-Tavio, H, Chiazza, F, O'Riordan, CE, Zeboudj, L, Mohammad, S, Collotta, D, Verta, R, Guisot, NES, Bunyard, P, Yaqoob, MM, Greaves, DR, Thiemermann, C
Background and Purpose Currently there are limited medicines available for the treatment of metabolic inflammation in diseases such as obesity and type 2 diabetes (T2D). Although initially associated with B‐ells, Bruton's tyrosine kinase (BTK) is p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1064::f423aaf8138a1c3306e37097c01d9273
https://ora.ox.ac.uk/objects/uuid:f11d90b0-752c-4153-82e3-3c99e505acff
https://ora.ox.ac.uk/objects/uuid:f11d90b0-752c-4153-82e3-3c99e505acff
Autor:
Dohnalkova E; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.; Department of Biological and Medical Sciences, Charles University, Hradec Kralove, Czech Republic., Bayer RL; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA., Guo Q; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA., Bamidele AO; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA., Kim Lee HS; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA., Valenzuela-Pérez L; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA., Krishnan A; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA., Pavelko KD; Department of Immunology, Mayo Clinic, Rochester, Minnesota, USA., Guisot NES; Redx Pharma Plc, Alderley Park, Macclesfield, UK., Bunyard P; Redx Pharma Plc, Alderley Park, Macclesfield, UK., Kim YB; Division of Endocrinology, Diabetes, and Metabolism, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA., Ibrahim SH; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.; Division of Pediatric Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA., Gores GJ; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA., Hirsova P; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
Publikováno v:
Hepatology communications [Hepatol Commun] 2023 Jun 02; Vol. 7 (6). Date of Electronic Publication: 2023 Jun 02 (Print Publication: 2023).
Autor:
Purvis GSD; William Harvey Research Institute, Queen Mary University of London, London, UK.; Sir William Dunn School of Pathology, University of Oxford, Oxford, UK., Collino M; Department of Drug Science and Technology, University of Turin, Turin, Italy., Aranda-Tavio H; Sir William Dunn School of Pathology, University of Oxford, Oxford, UK., Chiazza F; Department of Drug Science and Technology, University of Turin, Turin, Italy., O'Riordan CE; William Harvey Research Institute, Queen Mary University of London, London, UK., Zeboudj L; Sir William Dunn School of Pathology, University of Oxford, Oxford, UK., Mohammad S; William Harvey Research Institute, Queen Mary University of London, London, UK., Collotta D; Department of Drug Science and Technology, University of Turin, Turin, Italy., Verta R; Department of Drug Science and Technology, University of Turin, Turin, Italy., Guisot NES; Redx Pharma, Macclesfield, UK., Bunyard P; Redx Pharma, Macclesfield, UK., Yaqoob MM; William Harvey Research Institute, Queen Mary University of London, London, UK.; Centre for Diabetic Kidney Disease, Bart's and The London Hospital, London, UK., Greaves DR; Sir William Dunn School of Pathology, University of Oxford, Oxford, UK., Thiemermann C; William Harvey Research Institute, Queen Mary University of London, London, UK.; Centre for Diabetic Kidney Disease, Bart's and The London Hospital, London, UK.
Publikováno v:
British journal of pharmacology [Br J Pharmacol] 2020 Oct; Vol. 177 (19), pp. 4416-4432. Date of Electronic Publication: 2020 Aug 26.